Schlagwort: Clinical development
It’s time to focus on cardiovascular diseases!
To no one’s surprise, the oncology sector dominates the top deals in biopharma year by year. The industry simply ‘knows’ how to develop novel...
Can biopharma’s drug-focused R&D strategy remain profitable?
Since the 1990s, there has been a shift in focus within pharmaceutical R&D. It resulted in placing greater emphasis on areas such as cancer,...
Comparing late-stage vs. early-stage investment strategies
It is generally believed that, as projects advance in discovery research, little value is created because the products are still years away from the...